Lista de obras -

Abdominal dystonia in a patient with schizophrenia: a case report

artículo científico publicado en 2009

Beta-amyloid peptides enhance the proliferative response of activated CD4CD28 lymphocytes from Alzheimer disease patients and from healthy elderly.

artículo científico publicado en 2012

C-reactive protein and cortisol in drug-naïve patients with short-illness-duration first episode major depressive disorder: possible role of cortisol immunomodulatory action at early stage of the disease

artículo científico publicado en 2013

Clinical utility of chosen factors in predicting post-stroke depression: a one year follow-up

artículo científico publicado en 2015

Cognitive correlates in panic disorder as related to impulsivity - preliminary report.

artículo científico publicado en 2012

Cortisol as an indicator of hypothalmic-pitituary-adrenal axis dysregulation in patients with panic disorder: a literature review

artículo científico

Cortisol awakening response in drug-naïve panic disorder.

artículo científico publicado en 2016

Decision-making in panic disorder. Preliminary report

artículo científico publicado en 2017

Diffusion-weighted imaging of the brain in bipolar disorder: a case report

artículo científico publicado en 2015

Discontinuation-Emergent Signs and Symptoms Inventory--Polish translation of the discontinuation signs and symptoms checklist

artículo científico publicado en 2013

Fibromyalgia Syndrome - a multidisciplinary approach

artículo científico publicado en 2015

Immediate and delayed visual memory and recognition in patients with panic disorders

artículo científico publicado en 2013

Immune consequences of the spontaneous pro-inflammatory status in depressed elderly patients.

artículo científico publicado en 2004

Impulsivity and Panic Disorder: an exploratory study of psychometric correlates.

artículo científico publicado en 2015

Impulsivity in anxiety disorders. A critical review.

artículo científico

Impulsivity in panic disorder: neuropsychological correlates

artículo científico publicado en 2013

Increased plasma pro-inflammatory cytokine concentrations after myocardial infarction and the presence of depression during next 6-months.

artículo científico publicado en 2015

Intravenous clomipramine for depressive disorders

artículo científico publicado en 2002

Letter to Editor. Depression and cytokines - a different perspective. Author's response

artículo científico publicado en 2017

Low baseline salivary 3-methoxy-4-hydroxyphenylglycol (MHPG) in drug-naïve patients with short-illness-duration first episode major depressive disorder

artículo científico publicado en 2014

Low baseline salivary alpha-amylase in drug-naïve patients with short-illness-duration first episode major depressive disorder.

artículo científico publicado en 2014

MR findings in neurosyphilis--a literature review with a focus on a practical approach to neuroimaging

artículo científico publicado en 2013

Magnesium, C-reactive protein, and cortisol in drug-naïve patients with short illness-duration, first episode major depressive disorder: possible immunomodulatory role for magnesium

artículo científico publicado en 2016

Mirtazapine--an antidepressant

artículo científico publicado en 2002

Mood disorders in epilepsy - diagnostic and methodological considerations

artículo científico

Morning and afternoon serum cortisol level in patients with post-myocardial infarction depression.

artículo científico publicado en 2017

No relationship between baseline salivary alpha-amylase and State-Trait Anxiety Inventory Score in drug-naïve patients with short-illness-duration first episode major depressive disorder: An exploratory study.

artículo científico publicado en 2017

Overlapping phenomena of bipolar disorder and epilepsy--a common pharmacological pathway.

artículo científico

Peripheral blood lymphocyte subpopulations in patients with bipolar disorder type II

artículo científico publicado en 2019

Polymorphisms of the 5-HT2A receptor gene and clinical response to olanzapine in paranoid schizophrenia

artículo científico publicado en 2011

Polymorphisms of the histamine receptor (H1HR) gene are not associated with olanzapine-induced weight gain

artículo científico publicado en 2013

Prevalence of anxiety disorders in epilepsy

artículo científico publicado en 2017

Psychometric properties and diagnostic utility of the State-Trait Anxiety Inventory in epilepsy with and without comorbid anxiety disorder

scientific article published on 25 January 2019

Rapid-onset agranulocytosis in a patient treated with clozapine and lamotrigine

artículo científico publicado en 2015

Reevaluating the prevalence and diagnostic subtypes of depressive disorders in epilepsy.

artículo científico publicado en 2015

Relationship between the prevalence of depressive symptoms and metabolic syndrome. Results of the SOPKARD Project.

artículo científico publicado en 2006

Safety and efficacy of olanzapine versus perphenazine in patients with schizophrenia: results of multicenter, 18-week, double-blind clinical trial

artículo científico publicado el 1 de julio de 2003

Salivary 5-hydroxyindole acetic acid (5-HIAA) in drug-naïve patients with short-illness-duration first episode major depressive disorder

artículo científico publicado en 2014

Seizure following sudden zolpidem withdrawal.

artículo científico publicado en 2006

Ser9Gly polymorphism of the DRD3 gene is associated with worse premorbid social functioning and an earlier age of onset in female but not male schizophrenic patients

artículo científico publicado en 2010

Severe skin complications in patients treated with antidepressants: a literature review.

artículo científico publicado en 2014

Sibutramine-associated psychotic symptoms and zolpidem-induced complex behaviours: implications for patient safety

artículo científico publicado en 2013

Social support level in relation to metabolic syndrome--results of the SOPKARD study

artículo científico publicado en 2008

Symptom Frequency Characteristics of the Hamilton Depression Rating Scale of Major Depressive Disorder in Epilepsy.

artículo científico publicado en 2015

The efficacy of Cognitive-Behavioural Therapy (CBT) as related to sleep quality and hyperarousal level in the treatment of primary insomnia.

artículo científico publicado en 2012

Validation of the Hospital Anxiety and Depression Scale in patients with epilepsy

artículo científico publicado en 2016

Validation of the Polish Version of the Hamilton Rating Scale for Depression in patients with epilepsy.

artículo científico publicado en 2016

Validation of the Polish version of the Beck Depression Inventory in patients with epilepsy

artículo científico publicado en 2017

Zinc in drug-naïve patients with short-illness-duration first episode major depressive disorder: impact on psychopathological features

artículo científico publicado en 2014

Zolpidem abuse, dependence and withdrawal syndrome: sex as susceptibility factor for adverse effects.

artículo científico publicado en 2007

[Antipsychotic-induced weight gain--pharmacogenetic studies]

artículo científico publicado en 2006

[Atypical antipsychotic-induced weight gain]

artículo científico publicado en 2006

[Indicators of the persistent pro-inflammatory activation of the immune system in depression]

artículo científico publicado en 2006

[Serotoninergic system and limbic-hypothalamic-pituitary-adrenal axis (LHPA axis) in depression]

artículo científico publicado en 2006

Lista de obras de

Abdominal dystonia in a patient with schizophrenia: a case report

Beta-amyloid peptides enhance the proliferative response of activated CD4CD28 lymphocytes from Alzheimer disease patients and from healthy elderly.

C-reactive protein and cortisol in drug-naïve patients with short-illness-duration first episode major depressive disorder: possible role of cortisol immunomodulatory action at early stage of the disease

Clinical utility of chosen factors in predicting post-stroke depression: a one year follow-up

Cognitive correlates in panic disorder as related to impulsivity - preliminary report.

Cortisol as an indicator of hypothalmic-pitituary-adrenal axis dysregulation in patients with panic disorder: a literature review

Cortisol awakening response in drug-naïve panic disorder.

Decision-making in panic disorder. Preliminary report

Diffusion-weighted imaging of the brain in bipolar disorder: a case report

Discontinuation-Emergent Signs and Symptoms Inventory--Polish translation of the discontinuation signs and symptoms checklist

Fibromyalgia Syndrome - a multidisciplinary approach

Immediate and delayed visual memory and recognition in patients with panic disorders

Immune consequences of the spontaneous pro-inflammatory status in depressed elderly patients.

Impulsivity and Panic Disorder: an exploratory study of psychometric correlates.

Impulsivity in anxiety disorders. A critical review.

Impulsivity in panic disorder: neuropsychological correlates

Increased plasma pro-inflammatory cytokine concentrations after myocardial infarction and the presence of depression during next 6-months.

Intravenous clomipramine for depressive disorders

Letter to Editor. Depression and cytokines - a different perspective. Author's response

Low baseline salivary 3-methoxy-4-hydroxyphenylglycol (MHPG) in drug-naïve patients with short-illness-duration first episode major depressive disorder

Low baseline salivary alpha-amylase in drug-naïve patients with short-illness-duration first episode major depressive disorder.

MR findings in neurosyphilis--a literature review with a focus on a practical approach to neuroimaging

Magnesium, C-reactive protein, and cortisol in drug-naïve patients with short illness-duration, first episode major depressive disorder: possible immunomodulatory role for magnesium

Mirtazapine--an antidepressant

Mood disorders in epilepsy - diagnostic and methodological considerations

Morning and afternoon serum cortisol level in patients with post-myocardial infarction depression.

No relationship between baseline salivary alpha-amylase and State-Trait Anxiety Inventory Score in drug-naïve patients with short-illness-duration first episode major depressive disorder: An exploratory study.

Overlapping phenomena of bipolar disorder and epilepsy--a common pharmacological pathway.

Peripheral blood lymphocyte subpopulations in patients with bipolar disorder type II

Polymorphisms of the 5-HT2A receptor gene and clinical response to olanzapine in paranoid schizophrenia

Polymorphisms of the histamine receptor (H1HR) gene are not associated with olanzapine-induced weight gain

Prevalence of anxiety disorders in epilepsy

Psychometric properties and diagnostic utility of the State-Trait Anxiety Inventory in epilepsy with and without comorbid anxiety disorder

Rapid-onset agranulocytosis in a patient treated with clozapine and lamotrigine

Reevaluating the prevalence and diagnostic subtypes of depressive disorders in epilepsy.

Relationship between the prevalence of depressive symptoms and metabolic syndrome. Results of the SOPKARD Project.

Safety and efficacy of olanzapine versus perphenazine in patients with schizophrenia: results of multicenter, 18-week, double-blind clinical trial

Salivary 5-hydroxyindole acetic acid (5-HIAA) in drug-naïve patients with short-illness-duration first episode major depressive disorder

Seizure following sudden zolpidem withdrawal.

Ser9Gly polymorphism of the DRD3 gene is associated with worse premorbid social functioning and an earlier age of onset in female but not male schizophrenic patients

Severe skin complications in patients treated with antidepressants: a literature review.

Sibutramine-associated psychotic symptoms and zolpidem-induced complex behaviours: implications for patient safety

Social support level in relation to metabolic syndrome--results of the SOPKARD study

Symptom Frequency Characteristics of the Hamilton Depression Rating Scale of Major Depressive Disorder in Epilepsy.

The efficacy of Cognitive-Behavioural Therapy (CBT) as related to sleep quality and hyperarousal level in the treatment of primary insomnia.

Validation of the Hospital Anxiety and Depression Scale in patients with epilepsy

Validation of the Polish Version of the Hamilton Rating Scale for Depression in patients with epilepsy.

Validation of the Polish version of the Beck Depression Inventory in patients with epilepsy

Zinc in drug-naïve patients with short-illness-duration first episode major depressive disorder: impact on psychopathological features

Zolpidem abuse, dependence and withdrawal syndrome: sex as susceptibility factor for adverse effects.

[Antipsychotic-induced weight gain--pharmacogenetic studies]

[Atypical antipsychotic-induced weight gain]

[Indicators of the persistent pro-inflammatory activation of the immune system in depression]

[Serotoninergic system and limbic-hypothalamic-pituitary-adrenal axis (LHPA axis) in depression]